INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 28 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $123,271 | +1141.0% | 131,000 | +1090.9% | 0.00% | – |
| Q1 2023 | $9,933 | -3.2% | 11,000 | 0.0% | 0.00% | – |
| Q4 2022 | $10,258 | -6.7% | 11,000 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -99.3% | 11,000 | -99.2% | 0.00% | -100.0% |
| Q4 2021 | $1,493,000 | +69.1% | 1,454,000 | +70.3% | 0.00% | – |
| Q3 2021 | $883,000 | +462.4% | 854,000 | +469.3% | 0.00% | – |
| Q2 2021 | $157,000 | -6.0% | 150,000 | 0.0% | 0.00% | – |
| Q1 2021 | $167,000 | -89.0% | 150,000 | -88.9% | 0.00% | -100.0% |
| Q4 2020 | $1,523,000 | -76.8% | 1,357,000 | -77.5% | 0.00% | -80.0% |
| Q3 2020 | $6,555,000 | +26.9% | 6,041,000 | +13.7% | 0.01% | +25.0% |
| Q2 2020 | $5,164,000 | +127.8% | 5,313,000 | +95.7% | 0.00% | +100.0% |
| Q1 2020 | $2,267,000 | +511.1% | 2,715,000 | +603.4% | 0.00% | – |
| Q4 2019 | $371,000 | -83.7% | 386,000 | -87.9% | 0.00% | -100.0% |
| Q4 2018 | $2,279,000 | -69.2% | 3,200,000 | -63.6% | 0.00% | 0.0% |
| Q3 2018 | $7,407,000 | -67.7% | 8,800,000 | -64.8% | 0.00% | -71.4% |
| Q2 2018 | $22,950,000 | +272.9% | 25,000,000 | +257.1% | 0.01% | +133.3% |
| Q1 2018 | $6,154,000 | – | 7,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |